Medscape |
EMA Advisory Panel Greenlights New Diabetes Treatments
Medscape Fixed-dose ertugliflozin and metformin (Segluromet) is indicated in patients whose condition is not adequately controlled on their maximally tolerated dose of metformin alone, those who are taking their maximally tolerated doses of metformin in … and more » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.